tuberculosis Archives
NIH grant boosts international TB research consortium
Jun. 14, 2023—A new grant will help support Vanderbilt's RePORT Brazil, one of an international consortium’s six regional tuberculosis research programs.
Novel drugs have potential for treating tuberculosis
Apr. 24, 2023—Drug-resistant tuberculosis is on the rise, and novel antibacterial drugs called SPTs have potential for treating the deadly lung infection.
NIH grant supports TB research network in Brazil
Feb. 23, 2023—The National Institutes of Health has awarded a five-year, $5 million grant to Vanderbilt University Medical Center for continued support of the Brazil Regional Prospective Observational Research in Tuberculosis network, or RePORT-Brazil.
VUMC lands grant to build top-line biosafety facility
Sep. 29, 2022—Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.
New Clinician Spotlight: Rebecca (Ribka) Berhanu
Mar. 30, 2022—Rebecca Berhanu, MD, assistant professor of Medicine, has joined Vanderbilt's Division of Infectious Diseases as a clinician and researcher.
Confronting TB resistance
Jun. 11, 2018—Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.
HIV treatment and TB risk
Aug. 4, 2016—Tuberculosis (TB) remains an important public health problem, particularly among people infected with the human immunodeficiency virus (HIV).
Study explores gene’s role in protecting HIV patients from TB
Mar. 17, 2016—An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12.
Slight chemical change may improve TB treatments: study
Feb. 11, 2016—One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered.
Routine TB testing to resume Dec. 16
Dec. 12, 2013—Routine tuberculosis (TB) skin testing for Vanderbilt staff and faculty will resume Monday, Dec. 16, after temporarily being suspended since September due to a national shortage of the TB skin testing solution Tubersol.
Preserving antibiotic arsenal for TB
Oct. 30, 2013—Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.
Shortage forces suspension of routine tuberculosis testing
Aug. 29, 2013—Due to a national shortage of the tuberculosis (TB) test solution Tubersol, Occupational Health will temporarily suspend routine annual skin tests, effective Sept. 1, said Patricia Kinman, MSN, FNP-BC, manager of the Vanderbilt Occupational Health Clinic
